Australian Patent Office accepts bioAffinity Technologies' patent application for its platform technology to assess lung health and predict disease.
PAP is a rare lung condition that can be difficult to diagnose because it may mimic many other more common lung diseases,” ...
A major new study, which has recently begun recruiting, is hoped to lead to earlier detection of lung cancers.